top of page

CVDACTION

Our smart data tool CVDACTION makes it easier for clinicians to spot, treat and support patients who are at high risk of CVD.

CVDACTION

CVDACTION is a smart data tool that makes it easier for clinicians to spot patients who are at high risk of CVD and make sure they get the right treatment.

CVDACTION is a smart risk stratification tool that makes it easier for clinicians to spot patients who are at high risk of CVD and make sure they get the right treatment.

This will drive a step change in the prevention of heart attacks and strokes, and help deliver the UK Mission to reduce deaths from CVD by a quarter in ten years.

 

Benefits:

  • CVDACTION delivers highly actionable data, presented simply, with integrated clinical resources.

  • CVDACTION complements CVDPREVENT (the national primary care audit), and is designed to address the HOW of CVD prevention in real world primary care. 

  • CVDACTION is run on GP health care records and is also embedded into ECLIPSE, with easy to use dashboards at practice, network or system level.

  • CVDACTION routinely identifies every patient with cardio-renal-metabolic (CRM) conditions who is not on NICE recommended treatment.

  • Focusing on what matters most, CVDACTION integrates 130 key searches across 8 CRM conditions but is designed for simplicity, making it easy to prioritise, fit numbers to workflow and capacity, integrate co-morbidities and target health inequalities.

  • With this actionable data and wraparound implementation support CVDACTION helps GP teams adapt pathways and use of workforce to embed proactive care, treatment optimisation and efficient use of capacity as business as usual.

  • CVDACTION's comprehensive stratification and easy prioritisation helps practices achieve QOF and other targets.

BENEFITS FOR PRIMARY CARE TEAMS

  • Structured support for primary care teams to adapt ways of working.

  • Holistic, proactive care embedded as business-as-usual.

  • Increase efficiency, release capacity and deliver QOF.

  • Improve care and outcomes for patients.

BENEFITS FOR ICBs/NEIGHBOURHOODS

  • Enabling the Prevention Shift.

  • Huge reduction in serious cardio-vascular events in short time frame.

  • Rapid impact on activity, spend, productivity and outcomes. 

  • Enables at scale action on health inequalities

  • Return on investment within a year.

Watch an introduction to CVDACTION:

CVDACTION was developed in UCLPartners by a team led by Matt and Laura. The initial build was made possible by a generous unrestricted grant provided by Astra Zeneca and Boehringer Ingelheim. Into-Action.Health has an exclusive licence to deploy CVDACTION.

CVDACTION Mission

THE CVDACTION STORY

Learn more about CVDACTION's background

bottom of page